Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Oncology-focused development and commercialisation company More
Polyphor is a Swiss biotech company providing innovative, high quality products and services to big pharma and biotech customers. More
• Address unmet medical needs in infectious diseases and cancer, using innovative therapeutic protein variants identified from a proprietary and original use of natural human genetic variability More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Bionature's vision is to develop new technologies for the diagnosis, prevention and treatment of diseases that contribute to human aging. More
An innovative company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology, with applications in DNA vaccination and immuno- and gene therapies More
Late stage development of the treatments developed to Phase II/Out-licensing of IP rights More
Your selection
Browse By
- Industry sector
- Bioinformatics
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Basal cell carcinoma
- Melanoma
- Squamous cell carcinoma
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us